Bioresorbable scaffolds: rationale, current status, challenges, and future.
about
Neoatherosclerosis: Coronary stents seal atherosclerotic lesions but result in making a new problem of atherosclerosisTreatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patientsEverolimus-eluting stent platforms in percutaneous coronary intervention: comparative effectiveness and outcomesBioresorbable Scaffolds: Current Evidences in the Treatment of Coronary Artery DiseaseMacromolecular approaches to prevent thrombosis and intimal hyperplasia following percutaneous coronary interventionEchogenicity as a surrogate for bioresorbable everolimus-eluting scaffold degradation: analysis at 1-, 3-, 6-, 12- 18, 24-, 30-, 36- and 42-month follow-up in a porcine model.Degree of bioresorbable vascular scaffold expansion modulates loss of essential function.Vascular restoration therapy and bioresorbable vascular scaffold.Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial.Multiplicity of morphologies in poly (l-lactide) bioresorbable vascular scaffolds.Revascularization strategies for patients with stable coronary artery disease.Current and future perspectives on drug-eluting bioresorbable coronary scaffolds.Bioresorbable scaffolds for the treatment of coronary artery disease: current status and future perspective.The year in cardiology 2014: coronary intervention.Update on percutaneous intervention for left main coronary artery stenosis.From drug eluting stents to bioresorbable scaffolds; to new horizons in PCI.Bioresorbable drug-eluting scaffolds for treatment of vascular disease.Three-Year Clinical Outcome of Patients with Coronary Disease and Increased Event Risk Treated with Newer-Generation Drug-Eluting Stents: From the Randomized DUTCH PEERS Trial.Bioresorbable Vascular Scaffolds in a Real-World Patient Population-Results From a Mid-Term Angiographic Follow-Up.Coronary Artery Vessel Healing Pattern, Short and Long Term, After Implantation of the Everolimus-Eluting Bioresorbable Vascular Scaffold.A 12-month angiographic and optical coherence tomography follow-up after bioresorbable vascular scaffold implantation in patients with ST-segment elevation myocardial infarction.Thin strut bare metal stents in patients with atrial fibrillation: Is there still a need for BMS?A Combination of Drug-Eluting Stents and Bioresorbable Vascular Scaffolds in the Treatment of Multivessel Coronary Artery Disease.Stent thrombosis and optimal duration of dual antiplatelet therapy after coronary stenting in contemporary practice.Bioresorbable vascular scaffolds-time to vanish?Current status of clinically available bioresorbable scaffolds in percutaneous coronary interventions.Bioresorbable scaffold-the holy grail of percutaneous coronary intervention: fact or myth?How far have we come with bioresorbable vascular scaffolds, and where should we go?Bioresorbable scaffolds versus metallic stents in routine PCI: the plot thickens.Very late bioresorbable vascular scaffold thrombosis at 25 months post implantation.Bioresorbable drug eluting scaffolds-are bioresorbable stents ready for today's clinical practice?Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry.Mechanical behavior of polymer-based vs. metallic-based bioresorbable stents.Bioresorbable Scaffolds in Spontaneous Coronary Artery Dissection: Long-Term Follow-Up in 4 Patients.Early experience and favorable clinical outcomes of everolimus-eluting bioresorbable scaffolds for coronary artery disease in Korea.Magmaris: a new generation metallic sirolimus-eluting fully bioresorbable scaffold: present status and future perspectives.One-year clinical and computed tomography follow-up after implantation of bioresorbable vascular scaffolds in patients with coronary chronic total occlusions.Post-dilatation after implantation of bioresorbable everolimus- and novolimus-eluting scaffolds: an observational optical coherence tomography study of acute mechanical effects.Bioresorbable vascular scaffolds in coronary bifurcation lesions: The next frontiers?Edge-to-Edge Technique to Minimize Ovelapping of Multiple Bioresorbable Scaffolds Plus Drug Eluting Stents in Revascularization of Long Diffuse Left Anterior Descending Coronary Artery Disease.
P2860
Q26774540-81BAACCE-900F-4193-9AC7-43969A6DF20CQ26780172-48754992-4E9E-4F67-AA72-F67D3661212DQ26798582-0C3089B5-8C22-4830-805A-BA46B5FC562DQ28076491-5CB3CBC5-B3BF-4474-836B-42BEC6B8CF69Q28654633-3F6223A0-9CCE-4B06-AEA3-7623552CA798Q30415979-6D3D7294-F146-427A-AD5C-4761C9543594Q36096161-3616FA98-C353-4EC5-B53E-379616CDE42FQ36345101-21DEF54E-A89A-4F4C-887E-4753B2A6240DQ37285036-88014C97-0099-4B21-A0F7-599A45D32616Q37369411-7BCF812C-2EFA-4F21-A84F-DE6F1F3180AEQ38201161-34575A62-C073-4404-BC69-B2BDE1ECE83BQ38224405-A172177A-E6E9-40C0-938A-8363DA01DC96Q38236449-7DCE16F7-AFBA-4480-86F5-1C1A0C8B2F02Q38307432-2D30BF4B-7C33-47E4-8DED-A2BFABBA8F12Q38544557-DA0FD690-4B9B-4C1A-8507-C5A7E057BCCBQ38702003-5B75F225-B2D2-41EC-B23B-5EABC72114E8Q38728978-4977F2BF-1578-4A58-91AE-B7561D310621Q38818354-53D2B717-DDEE-4ED8-AF9A-78FB8A8E1605Q39665517-02E18C35-93F7-4CCB-9F1F-A9E439868E4BQ40339342-1DDBE32C-87A1-4B83-AB40-394750BB10E8Q40898662-3AD4DB8D-87FB-402E-95C7-22CAEE98F8CDQ41064298-6B15627F-286D-45CC-AE82-04016C96766DQ41270451-F11946CA-9D1C-4984-889F-6B7D543F6908Q41607661-A4E0CA41-6DD3-4A75-A845-7DDC0FD9B05AQ41860479-C03CC817-6C0B-4D80-A23F-4E2DE072809CQ41875719-AB8C8EBB-5A7B-4AF9-BF04-A3E7B5520E60Q41880257-588685E7-4738-41FC-B257-573BEF82BAE1Q42333622-747CEFCC-B44A-413B-AEC8-1AF840D99869Q42357329-BC4DCFF4-5620-4DCD-AAC4-A11F6C60E7F1Q42735069-3F270C47-9F42-4582-9B3A-9EF04ADC124CQ42751286-BEFBA5BC-0D31-41A2-9856-880713CB154BQ46093469-C7B927D3-C2A3-4410-B2F2-A8B02F6342C6Q46665953-14EF44A1-BCC1-4989-BCCE-89D0726BF94DQ47097517-A51C8D17-724A-45F8-B43D-0708A1452D5BQ47376464-78576458-FCE8-4E22-85B4-697AFB10C88DQ47954131-C66124F5-05E4-4982-9E5B-B6D5E8897F1CQ48130911-DEC43930-C794-4AD1-830B-F09F3AB522FDQ48290973-99D1DC2F-65B1-43EE-8677-3F10DBF2838CQ51044627-9522518F-5AB9-4C62-9B5E-695D87A277ADQ51310352-F03FBBB3-E28B-436E-9E55-50DB19F0ABAB
P2860
Bioresorbable scaffolds: rationale, current status, challenges, and future.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Bioresorbable scaffolds: rationale, current status, challenges, and future.
@ast
Bioresorbable scaffolds: rationale, current status, challenges, and future.
@en
Bioresorbable scaffolds: rationale, current status, challenges, and future.
@nl
type
label
Bioresorbable scaffolds: rationale, current status, challenges, and future.
@ast
Bioresorbable scaffolds: rationale, current status, challenges, and future.
@en
Bioresorbable scaffolds: rationale, current status, challenges, and future.
@nl
prefLabel
Bioresorbable scaffolds: rationale, current status, challenges, and future.
@ast
Bioresorbable scaffolds: rationale, current status, challenges, and future.
@en
Bioresorbable scaffolds: rationale, current status, challenges, and future.
@nl
P2093
P2860
P3181
P356
P1476
Bioresorbable scaffolds: rationale, current status, challenges, and future.
@en
P2093
Alexandre Abizaid
John Ormiston
Patrick Serruys
Ron Waksman
Yoshinobu Onuma
P2860
P304
P3181
P356
10.1093/EURHEARTJ/EHT542
P50
P577
2014-03-01T00:00:00Z